Elwood & Goetz Wealth Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Elwood & Goetz Wealth Advisory Group's REGN Position: Q2 2026 in Review
Elwood & Goetz Wealth Advisory Group reduced its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q2 2026, selling an estimated $3.4K and leaving 418 shares worth $261K. The position accounts for 0.04% of the portfolio, ranked #129.
Elwood & Goetz Wealth Advisory Group first reported a position in REGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $517K in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Elwood & Goetz Wealth Advisory Group held 418 shares of Regeneron Pharmaceuticals worth $261K as of Q2 2026.
- Elwood & Goetz Wealth Advisory Group sold 5 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.4K.
- Regeneron Pharmaceuticals made up 0.04% of Elwood & Goetz Wealth Advisory Group's portfolio in Q2 2026, its #129 holding.
- Elwood & Goetz Wealth Advisory Group first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
- Elwood & Goetz Wealth Advisory Group's Regeneron Pharmaceuticals position peaked at $517K in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Elwood & Goetz Wealth Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.